Product Profile
no_image no_image no_image no_image no_image no_image no_image no_image no_image no_image no_image no_image
PRODUCTS DISEASE PHARMACOVIGILANCE MEDCAL
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
GLIDABET
GLIDABET

GLIDABET

BRANDED
The main mechanism of action of gliclazide is by increasing insulin secretion by pancreatic beta cells.
Available at :
Share this article
Related Articles
c93f30afcf684e97e2d6f93369c71361.jpg
Insulin Glulisine in Pregnancy: Insights from Clinical Trial and Post Marketing Surveillance
by dr. Verawati Nur | 29 Sep 2025
968ccc63e034ac22bd18d87d4274ae6f.jpg
Simplification of T2DM Therapy with iGlarLixi: A Single Injection for Optimal Glycemic Control Throughout the Day
by dr. Alfredo Bambang, MBA | 26 Aug 2025
21514971c2afea8f5a3ab8af2af75df7.jpg
Are Stem Cells Potentially Effective in Type 1 Diabetes?
by dr. Hastarita Lawrenti | 25 Jul 2025
8095dd98a85c48b2268d8f3e9bc7d6a1.jpg
Efficacy and Safety of Second-Generation Basal Insulin in DM Patients with Impaired Renal Function
by dr. Alfredo Bambang, MBA | 24 Jul 2025
fe376df8a513e5870e749288c4a3c6a0.jpg
Pregabalin Appropriate for Diabetic Peripheral Neuropathy Patients with Higher HbA1c, Study Finds
by dr. Hastarita Lawrenti | 01 Jul 2025
5d952f48dd76878fe35a78f6415aeb15.jpg
.
by dr. Hastarita Lawrenti | 12 Mar 2025
ac78423f85dcaab94ac5fbd03567f53f.jpg
Strategies for Managing Type 2 Diabetes with FRC Iglarlixi During Ramadan Fasting
by dr. Risya Malida | 18 Feb 2025
d39289809f262d6390a20f8be895eab7.jpg
Potential Use of Stem Cells in Type 2 Diabetes Mellitus Patients
by dr. Hastarita Lawrenti | 21 Mar 2025
42e288db6eb41f9b50e8cf8870f649a1.jpg
Effectiveness of IGlarLixi in Improving Glycemic Control Based on Continuous Glucose Monitoring
by dr. Alfredo Bambang, MBA | 20 Dec 2024
735bc0a736ad6e49510ff824f3e120fe.jpg
RESTORE-G Data: 40% of T2DM Patients on GLP-1 RA Require Intensification After 2 Years
by dr. Alfredo Bambang, MBA | 17 Dec 2024